HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Proto-oncogene activity of melanoma antigen-A11 (MAGE-A11) regulates retinoblastoma-related p107 and E2F1 proteins.

Abstract
Melanoma antigen-A11 (MAGE-A11) is a low-abundance, primate-specific steroid receptor coregulator in normal tissues of the human reproductive tract that is expressed at higher levels in prostate cancer. Increased expression of MAGE-A11 enhances androgen receptor transcriptional activity and promotes prostate cancer cell growth. Further investigation into the mechanisms of MAGE-A11 function in prostate cancer demonstrated interactions with the retinoblastoma-related protein p107 and Rb tumor suppressor but no interaction with p130 of the Rb family. MAGE-A11 interaction with p107 was associated with transcriptional repression in cells with low MAGE-A11 and transcriptional activation in cells with higher MAGE-A11. Selective interaction of MAGE-A11 with retinoblastoma family members suggested the regulation of E2F transcription factors. MAGE-A11 stabilized p107 by inhibition of ubiquitination and linked p107 to hypophosphorylated E2F1 in association with the stabilization and activation of E2F1. The androgen receptor and MAGE-A11 modulated endogenous expression of the E2F1-regulated cyclin-dependent kinase inhibitor p27(Kip1). The ability of MAGE-A11 to increase E2F1 transcriptional activity was similar to the activity of adenovirus early oncoprotein E1A and depended on MAGE-A11 interactions with p107 and p300. The immunoreactivity of p107 and MAGE-A11 was greater in advanced prostate cancer than in benign prostate, and knockdown with small inhibitory RNA showed that p107 is a transcriptional activator in prostate cancer cells. These results suggest that MAGE-A11 is a proto-oncogene whose increased expression in prostate cancer reverses retinoblastoma-related protein p107 from a transcriptional repressor to a transcriptional activator of the androgen receptor and E2F1.
AuthorsShifeng Su, John T Minges, Gail Grossman, Amanda J Blackwelder, James L Mohler, Elizabeth M Wilson
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 288 Issue 34 Pg. 24809-24 (Aug 23 2013) ISSN: 1083-351X [Electronic] United States
PMID23853093 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Adenovirus E1A Proteins
  • Antigens, Neoplasm
  • CDKN1B protein, human
  • E2F1 Transcription Factor
  • E2F1 protein, human
  • MAGEA11 protein, human
  • MAS1 protein, human
  • Neoplasm Proteins
  • Proto-Oncogene Mas
  • RBL1 protein, human
  • Receptors, Androgen
  • Retinoblastoma-Like Protein p107
  • Cyclin-Dependent Kinase Inhibitor p27
  • E1A-Associated p300 Protein
  • EP300 protein, human
Topics
  • Adenovirus E1A Proteins (genetics, metabolism)
  • Animals
  • Antigens, Neoplasm (genetics, metabolism)
  • COS Cells
  • Chlorocebus aethiops
  • Cyclin-Dependent Kinase Inhibitor p27 (genetics, metabolism)
  • E1A-Associated p300 Protein (genetics, metabolism)
  • E2F1 Transcription Factor (genetics, metabolism)
  • HeLa Cells
  • Humans
  • Male
  • Neoplasm Proteins (genetics, metabolism)
  • Phosphorylation (genetics)
  • Prostatic Neoplasms (genetics, metabolism, pathology)
  • Protein Stability
  • Proto-Oncogene Mas
  • Receptors, Androgen (biosynthesis, genetics)
  • Retinoblastoma-Like Protein p107 (genetics, metabolism)
  • Transcription, Genetic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: